Search results
There is a page named "Seribantumab" on Wikipedia
- Seribantumab (INN; development code MM-121) is a monoclonal antibody designed for the treatment of cancer. It binds to extracellular domain of HER3 blocking...2 KB (124 words) - 00:09, 3 December 2023
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...68 KB (5,999 words) - 22:36, 15 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...149 KB (15,717 words) - 06:34, 13 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...92 KB (8,671 words) - 18:15, 17 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...31 KB (3,428 words) - 11:40, 29 July 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...121 KB (13,799 words) - 03:46, 30 July 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...42 KB (3,935 words) - 04:01, 30 April 2024- (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...14 KB (1,671 words) - 12:47, 23 April 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...24 KB (1,703 words) - 18:20, 18 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...43 KB (4,651 words) - 13:41, 27 July 2024- (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...13 KB (1,177 words) - 00:03, 12 August 2024
- (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...5 KB (412 words) - 23:17, 19 June 2023
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...17 KB (1,489 words) - 05:47, 7 April 2024
uveitis, rheumatoid arthritis psoriasis Selicrelumab mab human CD40 Seribantumab mab human ERBB3 (HER3) cancer Setoxaximab mab chimeric E. coli shiga...136 KB (4,020 words) - 07:14, 15 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...35 KB (4,573 words) - 03:04, 5 August 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...27 KB (3,071 words) - 04:54, 3 June 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...34 KB (3,021 words) - 12:39, 5 August 2024- (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...6 KB (596 words) - 05:15, 1 January 2024
- (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...110 KB (10,711 words) - 05:46, 12 July 2024
(heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth...60 KB (6,879 words) - 14:26, 16 July 2024
